US 9,808,496 B2
Use of a myrtle extract as an anti-biofilm agent against P. acnes
Joelle Luc, Fenouillet (FR); and Christel Fiorini-Puybaret, Toulouse (FR)
Assigned to PIERRE FABRE DERMO-COSMETIQUE, Boulogne-Billancourt (FR)
Appl. No. 14/413,436
Filed by PIERRE FABRE DERMO-COSMETIQUE, Boulogne-Billancourt (FR)
PCT Filed Jul. 8, 2013, PCT No. PCT/EP2013/064415
§ 371(c)(1), (2) Date Jan. 8, 2015,
PCT Pub. No. WO2014/009325, PCT Pub. Date Jan. 16, 2014.
Claims priority of application No. 12 56607 (FR), filed on Jul. 9, 2012.
Prior Publication US 2015/0190447 A1, Jul. 9, 2015
Int. Cl. A61K 36/00 (2006.01); A61K 36/61 (2006.01); A61K 8/97 (2017.01); A61Q 19/00 (2006.01); A61K 31/122 (2006.01); A61K 31/19 (2006.01); A61K 45/06 (2006.01)
CPC A61K 36/61 (2013.01) [A61K 8/97 (2013.01); A61K 31/122 (2013.01); A61K 31/19 (2013.01); A61K 45/06 (2013.01); A61Q 19/00 (2013.01)] 9 Claims
 
1. A method for treating acne or folliculitis decalvans comprising:
topically administering to a person in need thereof of an effective amount of a first dermatological composition containing myrtle extract at a concentration of 0.01% to 1% by weight, and further comprising the simultaneous, separate or sequential administration of a second dermatological composition containing at least one antibiotic.